longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

BOYUAN PLC

301617

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

About

BOYUAN PLC
BOYUAN PLC
301617.SZ

Shandong Boyuan Pharmaceutical & Chemical Co., Ltd. engages in the research and development, production, and sale of fine chemicals in China. It operates in four segments: Iodine Derivatives, Industrial Catalysts (precious metals), Organosilicon Series, and Chemiluminescent Materials. The company offers iodine derivatives, such as potassium iodide, sodium iodide, cesium iodide, potassium iodate, methyl iodide, diiodomethane, hydriodic acid, copper iodide, and iodotrimethylsilane; and fine chemicals, including hexamethyldisilazane, hexamethyldisilane, hexamethyldisiloxane, tris(dioxa-3,6-heptyl)amine, tris(2-(2-methoxyethoxy)ethyl)amine, and tris(3,6-dioxaheptyl)amine.

Profile

Company Name
Shandong Boyuan Pharmaceutical & Chemical Co., Ltd.
Market
SZSE
Founded
2008-08-06
Industry
--
Fiscal Year End
December 31
Website
www.boyuanchemical.com